Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease-Reference-Cited by-同舟云学术

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease

Published:2015-11-25 Issue:12 Volume:67 Page:3256-3261
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Suliman Yossra A.¹,Dobrota Rucsandra²,Huscher Dörte³,Nguyen-Kim Thi D. L.⁴,Maurer Britta⁴,Jordan Suzana⁴,Speich Rudolf⁴,Frauenfelder Thomas⁴,Distler Oliver⁴

Affiliation:

1. University Hospital Zurich, Zurich, Switzerland, and Assiut University Hospital; Assiut Egypt

2. University Hospital Zurich, Zurich, Switzerland, and Dr. I. Cantacuzino Hospital and Carol Davila University of Medicine and Pharmacy; Bucharest Romania

3. German Rheumatism Research Centre and Charité University Hospital; Berlin Germany

4. University Hospital Zurich; Zurich Switzerland

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.39405/fullpdf

Reference15 articles.

1. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

2. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis;Steele;Arthritis Care Res (Hoboken),2012

3. Interstitial lung disease in systemic sclerosis: a simple staging system;Goh;Am J Respir Crit Care Med,2008